Hemosil Silica Clotting Time
Activated Partial Thromboplastin. 510(k) K050221, from Instrumentation Laboratory CO (Bedford, MA). Product code GFO, class 2.
As of Nov 20, 2026, K050221 is an FDA 510(k) held by Instrumentation Laboratory CO, substantially equivalent on Mar 30, 2005 after 58 days, with no recalls tied to it in FDA's recall database.
- Review time: 58 days
- Recalls: 0
- Cited as a predicate by: 1 device
HemosIL Silica Clotting Time is intended for the detection of Lupus Anticoagulants in human citrated plasma on the IL Coagulation Systems by the use of screening (SCT Screen) and confirmatory (SCT Confirm) reagents sensitized to phospholipid dependent antibodies. For in vitro diagnostic use.
- Il Test Lac Screen (Claims Added To Acl Futura), Il Test Lac Confirm (Claims Addad To Acl Futura)K990302 · Instrumentation Laboratory CO · Apr 8, 1999
- HemosIL Silica Clotting TimeK160445 · Instrumentation Laboratory CO · Mar 16, 2016
- HemosIL Silica Clotting TimeK253957 · Instrumentation Laboratory (IL) Co. · Jan 9, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jan 31, 2005
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7925
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files